SE7807571L - Forfarande for framstellning av antigraviditetsvaccin - Google Patents

Forfarande for framstellning av antigraviditetsvaccin

Info

Publication number
SE7807571L
SE7807571L SE7807571A SE7807571A SE7807571L SE 7807571 L SE7807571 L SE 7807571L SE 7807571 A SE7807571 A SE 7807571A SE 7807571 A SE7807571 A SE 7807571A SE 7807571 L SE7807571 L SE 7807571L
Authority
SE
Sweden
Prior art keywords
antigravidity
vaccine
procedure
production
antigravidity vaccine
Prior art date
Application number
SE7807571A
Other languages
English (en)
Other versions
SE432706B (sv
Inventor
G P Talwar
Original Assignee
All India Inst Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by All India Inst Med filed Critical All India Inst Med
Publication of SE7807571L publication Critical patent/SE7807571L/sv
Publication of SE432706B publication Critical patent/SE432706B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0006—Contraceptive vaccins; Vaccines against sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/811—Drug, bio-affecting and body treating compositions involving sex selection or contraception
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/814—Pregnancy
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y10S436/817—Steroids or hormones
    • Y10S436/818—Human chorionic gonadotropin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/807—Hapten conjugated with peptide or protein
SE7807571A 1975-01-28 1978-07-05 Konceptionsforhindrande medel i form av ett immunogent konjugat av en berare och nitroderivatet av beta-hcg jemte forfarande for dess framstellning SE432706B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US54467775A 1975-01-28 1975-01-28

Publications (2)

Publication Number Publication Date
SE7807571L true SE7807571L (sv) 1978-07-05
SE432706B SE432706B (sv) 1984-04-16

Family

ID=24173127

Family Applications (2)

Application Number Title Priority Date Filing Date
SE7505411A SE432526B (sv) 1975-01-28 1975-05-12 Immunogent konjugat av koriongonandotropinfragment och stelkrampstoxid som konceptionsforhindrande medel, jemte forfarande for dess framstellning
SE7807571A SE432706B (sv) 1975-01-28 1978-07-05 Konceptionsforhindrande medel i form av ett immunogent konjugat av en berare och nitroderivatet av beta-hcg jemte forfarande for dess framstellning

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SE7505411A SE432526B (sv) 1975-01-28 1975-05-12 Immunogent konjugat av koriongonandotropinfragment och stelkrampstoxid som konceptionsforhindrande medel, jemte forfarande for dess framstellning

Country Status (11)

Country Link
US (1) US4161519A (sv)
AR (1) AR217615A1 (sv)
CA (1) CA1054937A (sv)
CH (1) CH614626A5 (sv)
DE (1) DE2518546A1 (sv)
DK (1) DK145283C (sv)
FI (1) FI54997C (sv)
IL (1) IL47177A (sv)
NL (1) NL7505412A (sv)
NO (1) NO145083C (sv)
SE (2) SE432526B (sv)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5006334A (en) * 1973-05-07 1991-04-09 The Ohio State University Antigenic modification of polypeptides
US4767842A (en) * 1973-05-07 1988-08-30 The Ohio State University Antigenic modification of polypeptides
US4762913A (en) * 1973-05-07 1988-08-09 The Ohio State University Antigenic modification of polypeptides
US6146633A (en) * 1973-05-07 2000-11-14 The Ohio State University Method for treatment of antigenically modified polypeptides
US6096318A (en) * 1973-05-07 2000-08-01 The Ohio State University Antigenically modified HCG polypeptides
US5698201A (en) * 1973-05-07 1997-12-16 The Ohio State University Method for treatment of antigenically modified polypeptides
US4384995A (en) * 1980-01-16 1983-05-24 The Ohio State University Antigenic modification of polypeptides
US4691006A (en) * 1983-03-04 1987-09-01 Ohio State University Antigenic modification of polypeptides
US4526716A (en) * 1981-11-20 1985-07-02 The Ohio State University Antigenic modification of polypeptides
US4302386A (en) * 1978-08-25 1981-11-24 The Ohio State University Antigenic modification of polypeptides
US6143305A (en) * 1973-05-07 2000-11-07 The Ohio State University Antigenically modified polypeptides composition
US4313871A (en) * 1978-02-06 1982-02-02 Research Corporation Antigen for early pregnancy test and contraceptive vaccine
US4397844A (en) * 1978-02-24 1983-08-09 Ciba-Geigy Corporation Antigen derivatives and processes for their preparation
US4268435A (en) * 1979-02-06 1981-05-19 Research Corporation Chorionic gonadotropin derived antigen for early pregnancy test and contraceptive vaccine
US4310455A (en) * 1979-04-17 1982-01-12 Research Corporation Antigen for early pregnancy test and contraceptive vaccine
US4376765A (en) * 1980-03-31 1983-03-15 Institut International De Pathologie Cellulaire Et Moleculaire Medicaments, their preparation and compositions containing same
US4749570A (en) * 1981-12-31 1988-06-07 The Governors Of The University Of Alberta Targeting conjugates of albumin and therapeutic agents
US4966888A (en) * 1985-07-08 1990-10-30 Cornell Research Foundation, Inc. hCG-hLH receptor and hCG-hLH receptor-hCG complex as antigens, antibodies thereto and contraceptive vaccine
US4556555A (en) * 1985-01-25 1985-12-03 North Carolina State University Process for the immunological neutering of animals
US4722889A (en) * 1985-04-02 1988-02-02 Leeco Diagnostics, Inc. Immunoassays using multiple monoclonal antibodies and scavenger antibodies
CA1239346A (en) * 1985-06-04 1988-07-19 Gursaran P. Talwar Birth control vaccine
US4855285A (en) * 1985-12-04 1989-08-08 The Ohio State University Research Foundation Antigenic modification of polypeptides
US4713366A (en) * 1985-12-04 1987-12-15 The Ohio State University Research Foundation Antigenic modification of polypeptides
US5817753A (en) 1985-12-04 1998-10-06 The Ohio State University Research Foundation Antigenic modification of polypeptides
US5762931A (en) * 1992-12-31 1998-06-09 National Institute Of Immunology Anti-cancer utility of HCG vaccines
AU4369596A (en) * 1994-11-21 1996-06-17 Virginia L. Scofield Sperm as vaccine vectors
US6319504B1 (en) 1996-06-24 2001-11-20 University Of Maryland Biotechnology Institute Treatment and prevention of HIV infection by administration of derivatives of human chorionic gonadotropin
US5997871A (en) * 1996-06-24 1999-12-07 University Of Maryland Biotechnology Insitute Treatment and prevention of cancer by administration of derivatives of human chorionic gonadotropin
US6583109B1 (en) 1997-06-24 2003-06-24 Robert C. Gallo Therapeutic polypeptides from β-hCG and derivatives
US7994278B1 (en) 1999-08-06 2011-08-09 Nobel Biosciences Llc Biologically active polypeptides derived from a novel early stage pregnancy factor designated maternin (MA)
US6716428B1 (en) 1999-10-06 2004-04-06 The Ohio State University Research Foundation Antigenic modification of polypeptides
EA007810B1 (ru) * 2001-11-16 2007-02-27 Фармекса А/С Иммуногенные миметики мультимерных белков с нерегулярными вставками т-клеточных эпитопов
US20030185845A1 (en) * 2001-11-16 2003-10-02 Steen Klysner Novel immunogenic mimetics of multimer proteins
US20040018973A1 (en) * 2002-01-25 2004-01-29 University Of Pittsburgh Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof
CN1756845A (zh) 2002-11-12 2006-04-05 A·B·德塞罗斯 腺病毒载体疫苗
KR20060015595A (ko) 2003-05-09 2006-02-17 파멕사 에이/에스 해독된 ｔｎｆ 및 그의 제조 방법
WO2005051991A2 (en) 2003-11-24 2005-06-09 Sidney Kimmel Cancer Center Mucin antigen vaccine
US8828957B2 (en) * 2003-12-11 2014-09-09 Microvax, Llc Methods for generating immunity to antigen
US20060286074A1 (en) * 2005-05-31 2006-12-21 Yucheng Tang Methods for immunotherapy of cancer
AU2006311752A1 (en) * 2005-11-07 2007-05-18 Sidney Kimmel Cancer Center CD40 ligand fusion protein vaccine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH622426A5 (en) * 1973-05-07 1981-04-15 Univ Ohio Contraceptive composition

Also Published As

Publication number Publication date
AR217615A1 (es) 1980-04-15
SE432526B (sv) 1984-04-09
CH614626A5 (sv) 1979-12-14
NL7505412A (nl) 1976-07-30
DE2518546A1 (de) 1976-07-29
CA1054937A (en) 1979-05-22
US4161519A (en) 1979-07-17
IL47177A0 (en) 1975-06-25
NO751680L (sv) 1976-07-29
NO145083C (no) 1982-01-27
FI54997B (fi) 1979-01-31
FI54997C (fi) 1979-05-10
FI751746A (sv) 1976-07-29
DK145283C (da) 1983-05-16
DK145283B (da) 1982-10-25
SE7505411L (sv) 1976-07-29
DK206975A (da) 1976-07-29
IL47177A (en) 1979-01-31
NO145083B (no) 1981-10-05
SE432706B (sv) 1984-04-16

Similar Documents

Publication Publication Date Title
SE7807571L (sv) Forfarande for framstellning av antigraviditetsvaccin
SE433208B (sv) Forfarande for framstellning av fenoletrar
SE427748B (sv) Forfarande for framstellning av frostherdig betong
SE419502B (sv) Forfarande for framstellning av ishockeyklubbor
SE7605139L (sv) Forfarande for framstellning av vattenupptagande cellulosaetrar
SE430336B (sv) Forbettrat forfarande for framstellning av amoxicillinfrihydrat
IT1062629B (it) Procedimento per la produzione di cantaxantina
SE7613628L (sv) Forfarande for framstellning av aromatiska uretaner
SE427839B (sv) Analogiforfaranden for framstellning av n-aryl-n-(1-l-4-piperidinyl)-aryl-acetamider
SE403477B (sv) Forfarande for famstellning av substituerade indoleniner
SE411453B (sv) Forfarande for framstellning av 3-fluorcefalosporiner
SE7606116L (sv) Forfarande for framstellning av 3-fenoxidbensaldehyder
RO69281A (ro) Procedeu pentru prepararea alchilamino-s-triazinelor
SE7604781L (sv) Forfarande for framstellning av diarylhydroxibutylaminer
IT1052928B (it) Procedimento per la produzione di floroglucina
NO143314C (no) Fremgangsmaate for fremstilling av akrylamid
SE404186B (sv) Forfarande for framstellning av cyklopropanolderivat
SE418489B (sv) Forfarande for framstellning av veteperoxid enligt antakinonforfarandet
SE7610637L (sv) Forfarande for framstellning av 2-alkylindaner
SE446726B (sv) Forfarande for framstellning av 16-metoxiprostaglandiner
SE7605753L (sv) Forfarande for framstellning av urandioxid
SE7604940L (sv) Forfarande for framstellning av sulfamylbensoesyror
SE7604669L (sv) Forfarande for framstellning av estrar av tiokarbamidsyror
SE7607026L (sv) Forfarande for framstellning av 5-alkylpikolinsyra
SE7605427L (sv) Forfarande for framstellning av klorcyan

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7807571-0

Effective date: 19890525

Format of ref document f/p: F